BioStem Technologies Inc. (BSEM)

[Juschilln]

To be honest, L2 doesn't look all that bad. With a decent, CONCRETE development, and a tad bit of interest we could easily be back at a penny before you could bat an eye. But again, we need something tangible not anymore "plans to . . . ", "potential revenue . . . ", "expect to generate . . . ", BS we've been fed for the past ~5yrs! But on the bright side, we are at that pivotal 5yr point when things start to come together and I hope this is the case with CGAQ at this point.

Once again, we'll see, the proof is in the product which we don't have right now.